ColeJ.O., GoldbergS.C., KlermanG.I.Phenothiazine treatment in acute schizophrenia.Arch Gen Psychiatry1964; 10: 246–261.
2.
GoldbergS.C., KlermanG.L., ColeJ.O.Changes in schizophrenic psychopathology and ward behaviour as a function of phenothiazine treatment.Br J Psychiatry1965; 111: 120–123.
3.
CurryS.H.Commentary: the strategy and value of neuroleptic drug monitoring.J Clin Psychopharmacol1985; 5: 263–271.
A recovering patient.“Can we talk?” The schizophrenic patient in psychotherapy.Am J Psychiatry1986; 143: 68–70.
15.
GlassL.L., KatzH.M., ScnitzerR.D.Psychotherapy of schizophrenia: an empirical investigation of the relationship of process to outcome.Am J Psychiatry1989; 146: 603–608.
16.
SartiP., CournosF.Medication and psychotherapy in the treatment of chronic schizophrenia.Psychiatr Clin North Am1990; 13: 215–228.
17.
SchulzS.C., ConleyR.R., KahnE.M.Nonresponders to neuroleptics: a distinct subtype. In: SchulzS.C., TammingaC.A., eds. Schizophrenia: scientific progress.New York: Oxford University Press,1989.